Identification of the activation domain of equine infectious anemia virus rev
- PMID: 8230455
- PMCID: PMC238195
- DOI: 10.1128/JVI.67.12.7317-7323.1993
Identification of the activation domain of equine infectious anemia virus rev
Abstract
Several members of the lentivirus family of complex retroviruses have been shown to encode proteins that are functionally equivalent to the Rev posttranscriptional regulatory protein of human immunodeficiency virus type 1 (HIV-1). Furthermore, the domain organization of HIV-1 Rev, featuring a highly basic N-terminal RNA binding domain and a leucin-rich C-terminal effector domain, has also been shown to be highly conserved among Rev proteins derived from not only the primate but also the ovine and caprine lentiviruses. Although it has therefore appeared highly probable that the lentivirus equine infectious anemia virus (EIAV) also encodes a Rev, the predicted amino acid sequence of this putative EIAV regulatory protein does not display any evident homology to the basic and leucine-rich motifs characteristic of other known Rev proteins. By fusion of different segments of the proposed EIAV Rev protein to the well-defined RNA binding domain of either HIV-1 or visna virus Rev, we have identified a segment of this EIAV protein that can efficiently substitute in cis for the otherwise essential activation motif. Interestingly, the minimal EIAV Rev activation motif identified in this study comprises approximately 18 amino acids located toward the protein N terminus that lack any evident similarity to the leucine-rich activation domains found in these other lentivirus Rev proteins. It therefore appears that the Rev protein of EIAV, while analogous in function to Rev proteins defined in lentiviruses of primate, ovine, and caprine origin, is nevertheless distinguished by an entirely novel domain organization.
Similar articles
-
Visna virus encodes a post-transcriptional regulator of viral structural gene expression.Proc Natl Acad Sci U S A. 1990 Oct;87(19):7497-501. doi: 10.1073/pnas.87.19.7497. Proc Natl Acad Sci U S A. 1990. PMID: 2170981 Free PMC article.
-
Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.J Virol. 2022 Dec 21;96(24):e0121022. doi: 10.1128/jvi.01210-22. Epub 2022 Nov 30. J Virol. 2022. PMID: 36448796 Free PMC article.
-
Structural and functional analysis of the visna virus Rev-response element.J Virol. 1992 Jun;66(6):3609-15. doi: 10.1128/JVI.66.6.3609-3615.1992. J Virol. 1992. PMID: 1316470 Free PMC article.
-
Molecular and biological characterization of equine infectious anemia virus Rev.Curr HIV Res. 2010 Jan;8(1):87-93. doi: 10.2174/157016210790416424. Curr HIV Res. 2010. PMID: 20210784 Review.
-
Rev variation during persistent lentivirus infection.Viruses. 2011 Jan;3(1):1-11. doi: 10.3390/v3010001. Epub 2011 Jan 11. Viruses. 2011. PMID: 21994723 Free PMC article. Review.
Cited by
-
Murine MusD retrotransposon: structure and molecular evolution of an "intracellularized" retrovirus.J Virol. 2007 Feb;81(4):1888-98. doi: 10.1128/JVI.02051-06. Epub 2006 Dec 6. J Virol. 2007. PMID: 17151128 Free PMC article.
-
Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.Mol Cell Biol. 2000 May;20(10):3550-7. doi: 10.1128/MCB.20.10.3550-3557.2000. Mol Cell Biol. 2000. PMID: 10779344 Free PMC article.
-
Probing RNA Conformational Equilibria within the Functional Cellular Context.Cell Rep. 2020 Feb 25;30(8):2472-2480.e4. doi: 10.1016/j.celrep.2020.02.004. Cell Rep. 2020. PMID: 32101729 Free PMC article.
-
Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.J Virol. 1994 Jun;68(6):3850-6. doi: 10.1128/JVI.68.6.3850-3856.1994. J Virol. 1994. PMID: 8189522 Free PMC article.
-
Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.J Virol. 2008 Dec;82(23):11889-901. doi: 10.1128/JVI.01537-08. Epub 2008 Sep 25. J Virol. 2008. PMID: 18818324 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources